Your browser doesn't support javascript.
loading
Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer.
Allegretti, Matteo; Fabi, Alessandra; Giordani, Elena; Ercolani, Cristiana; Romania, Paolo; Nisticò, Cecilia; Gasparro, Simona; Barberi, Vittoria; Ciolina, Maria; Pescarmona, Edoardo; Giannarelli, Diana; Ciliberto, Gennaro; Cognetti, Francesco; Giacomini, Patrizio.
Afiliação
  • Allegretti M; Oncogenomics and Epigenetics, IRCSS Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144, Rome, Italy.
  • Fabi A; Medical Oncology 1, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Giordani E; Present Address: Precision Medicine Breast Cancer Unit, Scientific Directorate, Health of Woman and Child Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Ercolani C; Oncogenomics and Epigenetics, IRCSS Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144, Rome, Italy.
  • Romania P; Pathology, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Nisticò C; Oncogenomics and Epigenetics, IRCSS Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144, Rome, Italy.
  • Gasparro S; Medical Oncology 1, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Barberi V; Medical Oncology 1, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Ciolina M; Specialization School in Oncology, Sapienza University of Rome, Rome, Italy.
  • Pescarmona E; Radiology and Diagnostic Imaging, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Giannarelli D; Pathology, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Ciliberto G; Biostatistical Unit, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Cognetti F; Scientific Direction, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  • Giacomini P; Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Mol Cancer ; 20(1): 151, 2021 11 29.
Article em En | MEDLINE | ID: mdl-34839818
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Biópsia Líquida / Ado-Trastuzumab Emtansina Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Biópsia Líquida / Ado-Trastuzumab Emtansina Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália